COX4I2-related pancreatic insufficiency-anemia-hyperostosis syndrome (EPIDACH; exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis) is a rare autosomal recessive mitochondrial cytochrome c oxidase (COX, Complex IV) disorder caused by biallelic variants in COX4I2. COX4 is an essential structural subunit of cytochrome c oxidase and exists as two tissue- biased isoforms encoded by separate genes: the ubiquitous COX4I1 and the hypoxia-responsive COX4I2, whose mRNA is relatively enriched in human pancreatic acinar cells. Loss-of-function of COX4I2 markedly reduces its expression and blunts the physiologic isoform response to hypoxia, producing a tissue-biased Complex IV deficiency. Unlike the encephalomyopathic / Leigh-like presentation typical of other nuclear COX-assembly defects, the founding cohort of four patients presented with a distinctive non-neurological triad: congenital exocrine pancreatic insufficiency with steatorrhea and malabsorption of lipid-soluble vitamins, dyserythropoietic anemia, and calvarial hyperostosis. The disorder was mapped by homozygosity mapping and conforms to the conserved Complex IV biogenesis-failure mechanism, with the lesion in a nuclear-encoded, acinar-biased COX structural subunit.
Ask a research question about COX4I2-Related Pancreatic Insufficiency-Anemia-Hyperostosis Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: COX4I2-Related Pancreatic Insufficiency-Anemia-Hyperostosis Syndrome
category: Mendelian
creation_date: "2026-06-21T00:00:00Z"
synonyms:
- EPIDACH
- Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis
- COX4I2-related cytochrome c oxidase deficiency
- Pancreatic insufficiency-anemia-hyperostosis syndrome
description: >
COX4I2-related pancreatic insufficiency-anemia-hyperostosis syndrome (EPIDACH;
exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial
hyperostosis) is a rare autosomal recessive mitochondrial cytochrome c oxidase
(COX, Complex IV) disorder caused by biallelic variants in COX4I2. COX4 is an
essential structural subunit of cytochrome c oxidase and exists as two tissue-
biased isoforms encoded by separate genes: the ubiquitous COX4I1 and the
hypoxia-responsive COX4I2, whose mRNA is relatively enriched in human pancreatic
acinar cells. Loss-of-function of COX4I2 markedly reduces its expression and
blunts the physiologic isoform response to hypoxia, producing a tissue-biased
Complex IV deficiency. Unlike the encephalomyopathic / Leigh-like presentation
typical of other nuclear COX-assembly defects, the founding cohort of four
patients presented with a distinctive non-neurological triad: congenital
exocrine pancreatic insufficiency with steatorrhea and malabsorption of
lipid-soluble vitamins, dyserythropoietic anemia, and calvarial hyperostosis.
The disorder was mapped by homozygosity mapping and conforms to the conserved
Complex IV biogenesis-failure mechanism, with the lesion in a nuclear-encoded,
acinar-biased COX structural subunit.
disease_term:
preferred_term: COX4I2-related exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis (EPIDACH)
term:
id: MONDO:0012992
label: pancreatic insufficiency-anemia-hyperostosis syndrome
parents:
- Mitochondrial Disease
- Inborn Error of Metabolism
classifications:
harrisons_chapter:
- classification_value: ENDOCRINOLOGY_METABOLISM
notes: >-
EPIDACH is a nuclear-encoded mitochondrial cytochrome c oxidase (Complex IV)
deficiency — an inborn error of oxidative-phosphorylation metabolism — placing
it in Harrison's Endocrinology and Metabolism part.
- classification_value: GENETICS_ENVIRONMENT_DISEASE
notes: >-
The disorder is a monogenic autosomal recessive condition caused by biallelic
COX4I2 variants identified through homozygosity mapping.
mechanistic_category:
- classification_value: mitochondrial disease
references:
- reference: PMID:19268275
title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
pathophysiology:
- name: COX4I2 Subunit Loss and Failed Complex IV Assembly
conforms_to: "complex_iv_assembly_deficiency#Complex IV Biogenesis Failure"
description: >
Biallelic COX4I2 variants markedly reduce expression of cytochrome c oxidase
subunit 4 isoform 2, an essential structural subunit of Complex IV. Because
the COX4I2-to-COX4I1 mRNA ratio is relatively high in human pancreatic acinar
cells and COX4I2 is the hypoxia-responsive isoform, loss of COX4I2 produces a
tissue-biased Complex IV biogenesis failure, with the additional loss of the
physiologic COX4I2 response to hypoxia. The lesion sits in the nuclear-encoded
structural-subunit arm of the COX biogenesis pathway.
cell_types:
- preferred_term: pancreatic acinar cell
term:
id: CL:0002064
label: pancreatic acinar cell
biological_processes:
- preferred_term: mitochondrial respiratory chain complex IV assembly
term:
id: GO:0033617
label: mitochondrial respiratory chain complex IV assembly
modifier: DECREASED
- preferred_term: COX4I2 response to hypoxia
term:
id: GO:0001666
label: response to hypoxia
modifier: DECREASED
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we excluded these disorders and identified, by using homozygosity mapping, a mutation in the COX4I2 gene"
explanation: Identifies a biallelic COX4I2 variant as the causal lesion via homozygosity mapping.
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The COX4 protein is an essential structural subunit of cytochrome c oxidase complex and has two isoforms, encoded by two different genes"
explanation: Establishes COX4I2 as an essential structural subunit of Complex IV, so its loss impairs holoenzyme assembly.
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The mutation is associated with marked reduction of COX4I2 expression and with striking attenuation of the physiologic COX4I2 response to hypoxia"
explanation: Documents reduced COX4I2 expression and loss of the hypoxia-isoform response underlying the assembly defect.
downstream:
- target: Impaired Terminal Electron Transfer and ATP Synthesis
causal_link_type: DIRECT
description: Loss of the essential COX4 structural subunit yields a catalytically deficient Complex IV holoenzyme.
- name: Impaired Terminal Electron Transfer and ATP Synthesis
conforms_to: "complex_iv_assembly_deficiency#Impaired Terminal Electron Transfer and ATP Synthesis"
description: >
The tissue-biased Complex IV deficiency blocks electron transfer from
cytochrome c to molecular oxygen and the coupled proton pumping, impairing
oxidative ATP synthesis in the tissues where COX4I2 predominates (notably
pancreatic acinar cells).
biological_processes:
- preferred_term: mitochondrial electron transport, cytochrome c to oxygen
term:
id: GO:0006123
label: mitochondrial electron transport, cytochrome c to oxygen
modifier: DECREASED
- preferred_term: ATP synthesis coupled electron transport
term:
id: GO:0042775
label: mitochondrial ATP synthesis coupled electron transport
modifier: DECREASED
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The COX4 protein is an essential structural subunit of cytochrome c oxidase complex and has two isoforms, encoded by two different genes"
explanation: Loss of an essential Complex IV structural subunit establishes the terminal-electron-transfer deficit downstream of failed assembly.
downstream:
- target: Tissue-Biased Bioenergetic Failure
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: The oxidative-phosphorylation deficit injures COX4I2-dependent tissues — exocrine pancreas, erythroid lineage, and calvarium.
- name: Tissue-Biased Bioenergetic Failure
conforms_to: "complex_iv_assembly_deficiency#High-Energy Tissue Dysfunction"
description: >
The bioenergetic deficit manifests in tissues where the COX4I2 isoform
predominates. Rather than the brainstem/Leigh-like pattern of most nuclear
COX defects, COX4I2 disease presents as a non-neurological triad — congenital
exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial
hyperostosis — reflecting the acinar-biased and hypoxia-responsive expression
of the affected isoform.
biological_processes:
- preferred_term: aerobic respiration
term:
id: GO:0009060
label: aerobic respiration
modifier: DECREASED
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis"
explanation: The non-neurological triad in the founding patients defines the tissue-biased manifestation of the bioenergetic deficit.
downstream:
- target: Exocrine pancreatic insufficiency
causal_link_type: DIRECT
description: Acinar-cell bioenergetic failure manifests as congenital exocrine pancreatic insufficiency.
- target: Dyserythropoietic anemia
causal_link_type: DIRECT
description: Erythroid-lineage involvement manifests as dyserythropoietic anemia.
- target: Calvarial hyperostosis
causal_link_type: DIRECT
description: Calvarial involvement manifests as hyperostosis of the skull vault.
phenotypes:
- name: Exocrine pancreatic insufficiency
description: >
Congenital exocrine pancreatic insufficiency, the cardinal feature of the
founding cohort and the basis for the recommendation to screen for COX4I2
variants in unexplained malabsorptive exocrine pancreatic insufficiency.
phenotype_term:
preferred_term: Exocrine pancreatic insufficiency
term:
id: HP:0001738
label: Exocrine pancreatic insufficiency
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis"
explanation: Congenital exocrine pancreatic insufficiency was a defining feature of the founding patients.
- name: Steatorrhea
description: >
Steatorrhea and malabsorption of lipid-soluble vitamins, the clinical
consequence of the exocrine pancreatic insufficiency.
phenotype_term:
preferred_term: Steatorrhea
term:
id: HP:0002570
label: Steatorrhea
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Steatorrhea and malabsorption of lipid-soluble vitamins due to exocrine pancreatic insufficiency"
explanation: Steatorrhea and fat-soluble vitamin malabsorption are the functional consequence of the exocrine pancreatic insufficiency.
- name: Malabsorption
description: >
Malabsorption of lipid-soluble vitamins (A, D, E, K) secondary to the
congenital exocrine pancreatic insufficiency; COX4I2 screening is
recommended in patients presenting with malabsorption.
phenotype_term:
preferred_term: Malabsorption of lipid-soluble vitamins
term:
id: HP:0002024
label: Malabsorption
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Steatorrhea and malabsorption of lipid-soluble vitamins due to exocrine pancreatic insufficiency"
explanation: Malabsorption of lipid-soluble vitamins is an explicit clinical consequence of the exocrine pancreatic insufficiency.
- name: Dyserythropoietic anemia
description: >
Dyserythropoietic anemia, the hematologic component of the EPIDACH triad;
COX4I2 screening is recommended in patients with dyserythropoietic anemia.
phenotype_term:
preferred_term: Dyserythropoietic anemia
term:
id: HP:0012130
label: Abnormal erythroid lineage cell morphology
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Mutation analysis of COX4I2 is warranted in patients with malabsorption due to exocrine pancreatic insufficiency and in patients with dyserythropoeitic anemia"
explanation: Dyserythropoietic anemia is a defining component of the syndrome and a recommended screening indication.
- name: Anemia
description: >
Anemia accompanying the dyserythropoiesis in the founding cohort.
phenotype_term:
preferred_term: Anemia
term:
id: HP:0001903
label: Anemia
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis"
explanation: Dyserythropoietic anemia in the founding patients establishes anemia as a core feature.
- name: Calvarial hyperostosis
description: >
Calvarial hyperostosis (thickening/sclerosis of the skull vault), the
skeletal component of the EPIDACH triad.
phenotype_term:
preferred_term: Calvarial hyperostosis
term:
id: HP:0004437
label: Cranial hyperostosis
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis"
explanation: Calvarial hyperostosis was a defining feature of the founding patients.
genetic:
- name: COX4I2 pathogenic variants causing EPIDACH
gene_term:
preferred_term: COX4I2
term:
id: hgnc:16232
label: COX4I2
inheritance:
- name: Autosomal recessive
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we excluded these disorders and identified, by using homozygosity mapping, a mutation in the COX4I2 gene"
explanation: Identification through homozygosity mapping in affected patients establishes autosomal recessive inheritance.
features: >
Biallelic COX4I2 variants cause this syndrome, identified by homozygosity
mapping in four affected patients. COX4I2 encodes the hypoxia-responsive,
acinar-biased isoform of the essential Complex IV structural subunit COX4;
the disease variant markedly reduces COX4I2 expression and blunts its
physiologic hypoxia response.
evidence:
- reference: PMID:19268275
reference_title: "Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We show that the ratio of COX4I2 to COX4I1 mRNA is relatively high in human acinar cells"
explanation: The acinar-biased COX4I2-to-COX4I1 expression ratio underlies the exocrine-pancreas-predominant phenotype.
treatments:
- name: Pancreatic Enzyme Replacement Therapy
description: >
Pharmacologic management of the exocrine pancreatic insufficiency with oral
pancreatic enzyme replacement therapy (pancrelipase); no curative therapy
exists.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: pancrelipase
term:
id: NCIT:C29345
label: Pancrelipase
- name: Fat-Soluble Vitamin Supplementation
description: >
Dietary supplementation of the lipid-soluble vitamins (A, D, E, K) that are
malabsorbed as a consequence of the exocrine pancreatic insufficiency.
treatment_term:
preferred_term: dietary intervention
term:
id: MAXO:0000088
label: dietary intervention
- name: Supportive Care
description: >
Multidisciplinary supportive care addressing the hematologic and skeletal
manifestations; management is symptomatic.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
notes: >
Scope note for curators: MONDO files MONDO:0012992 under mitochondrial
Complex IV deficiency (nuclear), and the entry conforms to the
complex_iv_assembly_deficiency module. However, EPIDACH is a distinct
multisystem syndrome (exocrine pancreas / erythroid / calvarium) rather than
the encephalomyopathic / Leigh-like presentation typical of the other nuclear
COX defects. This entry is added as a member of the
Mitochondrial_Complex_IV_Deficiency grouping (issue #4239): it conforms to the
complex_iv_assembly_deficiency#Complex IV Biogenesis Failure node and therefore
satisfies the grouping's NECESSARY_AND_SUFFICIENT module-conformance criterion
(the grouping's own evaluator flags it as a candidate member). Like the
existing SCO2 and COX15 members, its clinical-syndrome MONDO term
(MONDO:0012992) sits outside the MONDO:0033885 "nuclear type N" subtree but is
a genuine nuclear-encoded Complex IV structural-subunit defect, recorded in the
grouping's consistency note as an outside-subtree member. The specific founding variant
(a homozygous COX4I2 missense substitution; OMIM:612714) and any subsequent
cohorts are not asserted here beyond what the cited abstract supports.
Disease: COX4I2-related exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis (EPIDACH); MONDO:0012992 classifies it under mitochondrial complex IV (cytochrome c oxidase) deficiency MONDO: MONDO:0012992 | OMIM phenotype: 612714 | Gene: COX4I2 (HGNC:16232; OMIM:607976; chr20q11.21) | Inheritance: autosomal recessive
EPIDACH is an ultra-rare autosomal recessive multisystem disorder caused by a biallelic missense mutation in COX4I2, the gene encoding the lung/acinar-biased, hypoxia-responsive isoform 2 of structural subunit 4 (COX4) of cytochrome c oxidase (mitochondrial respiratory chain Complex IV). Unlike the encephalomyopathic / Leigh-like presentation typical of most nuclear COX-assembly defects, COX4I2 disease presents as a distinctive non-neurological triad: congenital exocrine pancreatic insufficiency (steatorrhea, malabsorption of lipid-soluble vitamins, failure to thrive), dyserythropoietic anemia, and calvarial hyperostosis. The mechanistic hallmark is tissue-biased Complex IV deficiency: COX4I2 is the predominant COX4 isoform in pancreatic acinar cells, so its loss selectively impairs oxidative phosphorylation in tissues that depend on it, while sparing tissues where the ubiquitous COX4I1 isoform predominates.
The primary human literature is exceptionally small and, after this sweep, considered complete. It comprises one primary report:
A separate ClinVar submission (NM_032609.3(COX4I2):c.1-6C>T, a 5′-UTR/splice-region
variant) is annotated to the same condition but is not backed by a distinct primary
clinical report and was not used as evidence.
No curative therapy exists; management is supportive — pancreatic enzyme replacement therapy (PERT) for the exocrine pancreatic insufficiency, fat-soluble vitamin supplementation, and transfusion/supportive care for the anemia.
Targeted searches (PubMed/Google Scholar-style queries via WebSearch, plus a fetch of the 2022 Frontiers in Pediatrics review of congenital exocrine pancreatic insufficiency etiologies) were run to find any COX4I2/EPIDACH primary literature published after the 2009 founding report:
Result: no new primary papers. The sweep surfaced no additional families, no novel pathogenic variants beyond the founder allele, and no new functional studies. The entry's reliance on the single PMID:19268275 citation is therefore appropriate and reflects a complete primary literature, not an under-curated one. This mirrors the situation for sibling ultra-rare nuclear COX-deficiency leaf entries (e.g. PET100, TACO1) where the primary literature is likewise near-exhaustive.
EPIDACH is a member of the high-NEC-risk class flagged in #3889/#4239 (a gene-numbered/eponymic mitochondrial-deficiency series with a "sanity-check membership" caveat in the issue). The identity anchors were cross-checked:
complex_iv_assembly_deficiency module on mechanistic grounds (subunit loss →
Complex IV biogenesis failure → tissue-biased bioenergetic failure) but the
decision to add it to the Mitochondrial_Complex_IV_Deficiency grouping is left
to a human maintainer (documented in the entry's notes).No disease-modifying therapy. Supportive management curated in the entry:
NM_032609.3(COX4I2):c.1-6C>T annotated to EPIDACH
(no distinct primary clinical report; not used as evidence)